Prevalence of abnormal findings in foetal echocardiograms at the Santander University Hospital, Bucaramanga, Colombia, 2007-2013

Authors

  • Jorge Eduardo Peñaloza-Wandurraga
  • Sandra Prada-Motta
  • Juan Carlos Otero-Pinto

DOI:

https://doi.org/10.18597/rcog.13

Keywords:

Foetal heart, congenital heart disease, echocardiography, doppler echocardiography

Abstract

Objectives: To describe the prevalence of abnormal findings in foetal echocardiograms, and the most frequent abnormalities found with this imaging study.

Materials and methods: Cross-sectional study in patients with an indication for foetal echocardiography because of the presence of risk factors or suspected abnormal findings on ultrasound. The patients were seen at the maternal-foetal unit of the Santander University Hospital in Bucaramanga, Colombia, a level III complexity institution serving the population under the government-subsidized health system, during the period between 2007- 2013. Sampling was consecutive. Echocardiography was performed by one of the investigators using a MEDISON V10 ultrasound machine with 2D echocardiography, colour Doppler and spectral Doppler. Gestational age (GA), ejection fraction (EF) and abnormalities are described. Abnormalities were divided into 5 subgroups: right AV node abnormality; left AV node abnormality; conotruncal abnormalities; septal abnormalities; and conduction disorders. Results are presented using descriptive statistics. 

Results: During the period described, 99 foetal echocardiograms were performed. Of those, 40 were described as normal (40.4%) and 56 were categorized as abnormal (59.6%). Abnormal findings included 25.3% septal abnormalities (33); 24.6% conotruncal abnormalities (32); 20.7% right AV node abnormalities (27); 9.2% left AV node abnormalities (12); and 5.3% conduction disorders (7). 

Conclusions: In our institution, the prevalence of abnormal findings in foetal echocardiograms in pregnant women with an indication for echocardiography was 59.6%. 

Author Biographies

Jorge Eduardo Peñaloza-Wandurraga

Estudiante de X semestre de Medicina, Universidad Industrial de Santander. Grupo de investigación GINO, Bucaramanga (Colombia).

Sandra Prada-Motta

Estudiante de X semestre de Medicina, Universidad Industrial de Santander. Grupo de investigación GINO, Bucaramanga (Colombia).

Juan Carlos Otero-Pinto

Médico, Juan N. Corpas. Especialista en Ginecología y Obstetricia y Medicina Materno Fetal, Universidad de Costa Rica. Fellow en ecocardiografía fetal y ecografía en 3D, Texas Tech University (USA). Profesor, Universidad Industrial de Santander, Bucaramanga (Colombia).

References

Araújo Júnior E, Rolo LC, Rocha LA, Nardozza LM, Moron AF. The value of 3D and 4D assessments of the fetal heart. Int J Womens Health. 2014;6:501-7.

Mtsac PM, Guevara CG, Allan LD. Ecocardiografía fetal. Rev argent cardiol. 2008;76:392-8.

Unidad de Ecocardiografía Fetal, Servicio de Medicina Materno-Fetal. Hospital Universitario-Clínic de Barcelona. Protocolo ecocardiografía fetal; 2010. Disponible en: http://www.medicinafetalbarcelona.org

Chaubal N, Chaubal J. Fetal echocardiography. Indian J Radiol Imaging. 2009;19:60-8.

Marantz P, García C. Ecocardiografía fetal. Rev argent cardiol. 2008;76:392-8.

Li Y, Hua Y, Fang J, Wang C, Qiao L, et al. Performance of different scan protocols of fetal echocardiography in the diagnosis of fetal congenital heart disease: a systematic review and meta-analysis. PLoS One. 2013;8:e65484.

Center for Diseases Control and prevention. Con¬genital Hearth Defect. Data & Statistics [visitado 2015 Mar 15]. Disponible en: http://www.cdc.gov/ncbddd/heartdefects/data.html

Başpinar O, Karaaslan S, Oran B, Baysal T, Elmaci AM, Yorulmaz A. Prevalence and distribution of children with congenital heart diseases in the central Anatolian region, Turkey. Turk J Pediatr. 2006;48:237-43.

La salud en Colombia: diez años de información. Bogotá: Ministerio de Salud. Dirección de Sistemas de Información; 1994.

Baltaxe E, Zarante I. Prevalencia de malformaciones cardiacas congénitas en 44.985 nacimientos en Colombia. Arch Cardiol Méx. 2006;76:263-8.

Secretaría de Salud de Santander. Boletín de Prensa N° 30. El lunes, lanzamiento del programa Mi Corazón por Santander. Diciembre 2006. Disponible en: http://www.saludsantander.gov.co/

Yeo L, Romero R. Fetal Intelligent Navigation Echocardiography (FINE): a novel method for rapid, simple, and automatic examination of the fetal heart. Ultrasound Obstet Gynecol. 2013;42:268-84.

Eapen RS, Rowland DG, Franklin WH. Effect of prenatal diagnosis of critical left heart obstruction on perinatal morbidity and mortality. Am J Perinatol. 1998; 4:237-42.

Holland BJ, Myers JA, Woods CR Jr. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis. Ultrasound Obstet Gynecol. 2015;45:631-8.

Fung A, Manlhiot C, Naik S, Rosenberg H, Smythe J, Lougheed, et al. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc. 2013;2:e000064.

Rocha L, Araújo E, Nardozza L, Moron A. Screening of fetal congenital heart disease: the challenge continues. Rev Bras Cir Cardiovasc. 2013;28:V-VII.

Ozbarlas N, Erdem S, Küçükosmanoğlu, Seydaoğlu G, Demir C, Evrüke C, et al. Prevalence and distribution of structural heart diseases in high and low risk pregnancies. Anadolu Kardiyol Derg. 2011;11:125-30.

International Society of Ultrasound in Obstetrics and Gynecology, Carvalho J, Allan L, Chaoui R, Copel J, DeVore G, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol. 2013;41:348-59.

Foy P, Wheller J, Samuels P, Evans KD. Evaluation of the fetal heart at 14 to 18 weeks’ gestation in fetuses with a screening nuchal translucency greater than or equal to the 95th percentile. J Ultrasound Med. 2013; 32:1713-9.

Rossi A, Prefumo F. Accuracy of ultrasonography at 11- 14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol. 2013; 122:1160-7.

Bilardo C, Müller M, Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol. 2001;17:288-94.

Özkutlu S, Akça T, Kafali G, Beksaç S. The results of fetal echocardiography in a tertiary center and comparison of low- and high-risk pregnancies for fetal congenital heart defects. Anadolu Kardiyol Derg. 2010;10:263-9.

Hinojosa C, Luis M, Veloz M, Puello T, Arias M, Barra U, et al. Diagnóstico y frecuencia de cardiopatía fetal mediante ecocardiografía en embarazos con factores de alto riesgo. Ginecol Obstet Mex. 2006;74:645-56.

Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J. 2009;157:467-73.

Ochoa M, Hernández R, Hernández J, Luna S, Padilla Y. Diagnóstico prenatal de cardiopatía fetal. Ginecol Obstet Mex. 2007;75:509-14.

How to Cite

1.
Peñaloza-Wandurraga JE, Prada-Motta S, Otero-Pinto JC. Prevalence of abnormal findings in foetal echocardiograms at the Santander University Hospital, Bucaramanga, Colombia, 2007-2013. Rev. colomb. obstet. ginecol. [Internet]. 2015 Jun. 30 [cited 2024 May 16];66(2):110-5. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/13

Downloads

Download data is not yet available.

Published

2015-06-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo